Martina Wespel Boehringer Ingelheim Pharma GmbH & Co. KG
![Martina Wespel Martina Wespel](https://pda.org/images/default-source/speaker-photos/martina-wespel-1980814.jpeg.jpeg?sfvrsn=ed39d851_1)
Martina Wespel Boehringer Ingelheim Pharma GmbH & Co. KG Process Expert Late Stage Downstream
Martina Wespel is a process expert in a late stage downstream laboratory at Boehringer Ingelheim, with more than 27 years experience in Downstream process development for commercial manufacturing. For the last 6 years, she starts to examine the impact of endotoxin removal during downstream processing. She published the first endotoxin removal study by considering the impact of endotoxin masking.